Lista de obras - Juergen Reichardt - Dominio Público Uruguay

A genetic factor for age-related cataract: identification and characterization of a novel galactokinase variant, "Osaka," in Asians

artículo científico publicado en 2001

A prevalent missense substitution that modulates activity of prostatic steroid 5alpha-reductase.

artículo científico publicado en 1997

A reliable PCR amplification method for microdissected tumor cells obtained from paraffin-embedded tissue

scientific article published on 01 December 1999

A renaissance of "biochemical genetics"? SNPs, haplotypes, function, and complex diseases.

artículo científico publicado en 2004

Androgen metabolic genes in prostate cancer predisposition and progression.

artículo científico publicado en 2005

Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility

scientific article published on 01 October 1998

Androgen receptor CAG repeat length and TMPRSS2:ETS prostate cancer risk: results From the Prostate Cancer Prevention Trial.

artículo científico publicado en 2014

Androgens and the molecular epidemiology of prostate cancer.

artículo científico publicado en 2008

Association between two polymorphisms in the SRD5A2 gene and serum androgen concentrations in British men.

artículo científico publicado en 2003

Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial

artículo científico publicado en 2016

Association of galactose-1-phosphate uridyltransferase activity and N314D genotype with the risk of ovarian cancer

artículo científico publicado en 2002

Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA

artículo científico publicado en 1999

Association of the G289S single nucleotide polymorphism in the HSD17B3 gene with prostate cancer in Italian men.

artículo científico publicado en 2002

Associations between polymorphisms in the steroid 5-alpha reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer

artículo científico publicado en 2005

Associations of serum sex steroid hormone and 5α-androstane-3α,17β-diol glucuronide concentrations with prostate cancer risk among men treated with finasteride

artículo científico publicado en 2012

Biochemical and molecular studies of 132 patients with galactosemia.

artículo científico publicado en 1994

Biochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type II

scientific journal article

Characteristics of women with a family history of ovarian cancer. I. Galactose consumption and metabolism

artículo científico publicado en 1994

Characterization of a novel biochemical abnormality in galactosemia: deficiency of glycolipids containing galactose or N-acetylgalactosamine and accumulation of precursors in brain and lymphocytes

artículo científico publicado en 1991

Characterization of two missense mutations in human galactose-1-phosphate uridyltransferase: different molecular mechanisms for galactosemia.

artículo científico publicado en 1992

Characterization of two stop codon mutations in the galactose-1-phosphate uridyltransferase gene of three male galactosemic patients with severe clinical manifestation

artículo científico publicado en 1995

Conservation of short patches of amino acid sequence amongst proteins with a common function but evolutionarily distinct origins: implications for cloning genes and for structure-function analysis

artículo científico publicado en 1988

Correlation of cognitive, neurologic, and ovarian outcome with the Q188R mutation of the galactose-1-phosphate uridyltransferase gene.

artículo científico publicado en 1994

Current progress in using vitamin D and its analogs for cancer prevention and treatment ⬇️

artículo científico publicado el 1 de junio de 2012

Differential expression of steroid 5alpha-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancer.

artículo científico publicado en 2010

Effect of finasteride on serum androstenedione and risk of prostate cancer within the prostate cancer prevention trial: differential effect on high- and low-grade disease

artículo científico publicado en 2015

Evidence for an association between the SRD5A2 (type II steroid 5 alpha-reductase) locus and prostate cancer in Italian patients.

artículo científico publicado en 2000

Expression of galactose-1-phosphate uridyltransferase in the anterior pituitary of rat during the estrous cycle

artículo científico publicado en 1996

Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention Trial

artículo científico publicado en 2015

Finasteride metabolism and pharmacogenetics: new approaches to personalized prevention of prostate cancer.

artículo científico publicado en 2010

First International Conference on Chemoprevention of Prostate Cancer. Overview consensus statement

artículo científico publicado en 2004

Galactose-1-phosphate uridyl transferase (GALT) genotype and phenotype, galactose consumption, and the risk of borderline and invasive ovarian cancer (United States).

artículo científico publicado en 2002

Genetic basis of galactosemia

artículo científico publicado el 1 de enero de 1992

Genetic variability of the human SRD5A2 gene: implications for prostate cancer risk.

artículo científico publicado en 1995

Genetic variation of 3 beta-hydroxysteroid dehydrogenase type II in three racial/ethnic groups: implications for prostate cancer risk

artículo científico publicado en 1997

Genomic analysis of cancer tissue reveals that somatic mutations commonly occur in a specific motif.

artículo científico publicado en 2009

Genomic biomarkers, androgen pathway and prostate cancer.

artículo científico publicado en 2007

Genomics in breast and prostate cancer: assessment of the current state and future perspectives.

artículo científico publicado en 2006

Genomics is changing personal healthcare and medicine: the dawn of iPH (individualized preventive healthcare).

artículo científico publicado en 2015

Hormones and prostate cancer: current perspectives and future directions

artículo científico publicado en 2002

Human UDP-galactose 4' epimerase (GALE) gene and identification of five missense mutations in patients with epimerase-deficiency galactosemia

artículo científico publicado en 1998

Human genetics and genomics meetings going virtual: practical lessons learned from two international meetings in early 2020

artículo científico publicado en 2020

Identification and characterization of somatic steroid 5alpha-reductase (SRD5A2) mutations in human prostate cancer tissue

artículo científico publicado en 2004

Identification of genomic aberrations in hemangioblastoma by droplet digital PCR and SNP microarray highlights novel candidate genes and pathways for pathogenesis

artículo científico publicado en 2016

In vitro read-through of phenylalanine hydroxylase (PAH) nonsense mutations using aminoglycosides: a potential therapy for phenylketonuria

artículo científico publicado en 2013

In vivo and in vitro expression of rat galactose-1-phosphate uridyltransferase (GALT) in the developing central and peripheral nervous system

artículo científico publicado en 1996

Increasing PCR sensitivity for amplification from paraffin-embedded tissues

artículo científico publicado en 2002

Information symmetries in irreversible processes.

artículo científico publicado en 2011

Linkage disequilibrium between a SacI restriction fragment length polymorphism and two galactosemia mutations

artículo científico publicado en 1995

Modeling single nucleotide polymorphisms in the human AKR1C1 and AKR1C2 genes: implications for functional and genotyping analyses

artículo científico publicado en 2010

Molecular analysis of 11 galactosemia patients.

artículo científico publicado en 1991

Molecular basis of disorders of human galactose metabolism: past, present, and future.

artículo científico publicado en 2000

Molecular basis of galactosemia: mutations and polymorphisms in the gene encoding human galactose-1-phosphate uridylyltransferase

artículo científico publicado en 1991

Molecular characterization of galactosemia (type 1) mutations in Japanese.

artículo científico publicado en 1995

Molecular characterization of the H319Q galactosemia mutation.

artículo científico publicado en 1993

Molecular characterization of two galactosemia mutations and one polymorphism: implications for structure-function analysis of human galactose-1-phosphate uridyltransferase.

artículo científico publicado en 1992

Molecular cloning, characterization, and mapping of a full-length cDNA encoding human UDP-galactose 4'-epimerase

artículo científico publicado en 1995

Molecular epidemiology of hormone-metabolic loci in prostate cancer

artículo científico publicado en 2001

Molecular epidemiology of prostate cancer: hormone-related genetic loci

artículo científico publicado en 2007

Multiplex automated primer extension analysis: simultaneous genotyping of several polymorphisms.

artículo científico publicado en 2001

Mutations in galactosemia

artículo científico publicado en 1995

No association between the SRD5A2 gene A49T missense variant and prostate cancer risk: lessons learned

artículo científico publicado en 2008

Novel age-dependent targets in vestibular schwannomas.

artículo científico publicado en 2014

On the molecular nature of the Duarte variant of galactose-1-phosphate uridyl transferase (GALT).

artículo científico publicado en 1994

PCR-free method detects high frequency of genomic instability in prostate cancer.

scientific article published on December 2009

Pharmacogenetic analysis of human steroid 5 alpha reductase type II: comparison of finasteride and dutasteride

artículo científico publicado en 2005

Pharmacogenetics of human androgens and prostate cancer--an update.

artículo científico publicado en 2004

Pharmacogenomics of brain cancer and personalized medicine in malignant gliomas

artículo científico publicado en 2008

Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.

artículo científico publicado en 2001

Quo vadis, genoma? A call to pipettes for biochemists

scientific article published on 05 November 2007

Realizing the full potential of the sequenced human genome

scientific article published on 28 March 2008

Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial

artículo científico publicado en 2011

Robustness of gene expression profiling in glioma specimen samplings and derived cell lines.

artículo científico publicado en 2005

Schwannomas exhibit distinct size-dependent gene-expression patterns.

artículo científico publicado en 2015

Screening of nine SLC25A13 mutations: their frequency in patients with citrin deficiency and high carrier rates in Asian populations

article

Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial

artículo científico publicado en 2015

Sex steroid hormones and genetic susceptibility to breast and prostate cancer

artículo científico publicado en 1998

Single nucleotide differences (SNDs) continue to contaminate the dbSNP database with consequences for human genomics and health

article

Single nucleotide differences (SNDs) in the dbSNP database may lead to errors in genotyping and haplotyping studies

artículo científico publicado en 2010

Some spectroscopic views of the CuA site in cytochrome c oxidase preparations

artículo científico publicado en 1988

Spectra of intermediates in oxidation and reduction of cytochrome c oxidase

artículo científico publicado en 1982

Steroid 5-alpha reductase type II V89L substitution is not associated with risk of prostate cancer in a multiethnic population study.

artículo científico publicado en 2002

Studies of DNA in galactose-1-phosphate uridyltransferase deficiency and the Duarte variant in Germany

scientific article published on 01 January 1994

The 3rd Pacific Rim meeting on breast and prostate cancer: progress in hormonal carcinogenesis and the enduring influence of Ron Ross

scientific article published on 01 May 2007

The fundamental importance of human galactose metabolism: lessons from genetics and biochemistry ⬇️

artículo científico publicado el 1 de marzo de 1998

The future of the human SNP identification: which individuals to sequence?

artículo científico publicado en 2009

The role of human demographic history in determining the distribution and frequency of transferase-deficient galactosaemia mutations

artículo científico publicado en 2009

Three new mutations (P183T, V150L, 528insG) and eleven sequence polymorphisms in Italian patients with galactose-1-phosphate uridyltransferase (GALT) deficiency

article

Transition of a clinical trial into translational research: the prostate cancer prevention trial experience.

artículo científico publicado en 2010

Translesion DNA polymerases and cancer

artículo científico publicado en 2012

Turnover of cytochrome c oxidase from Paracoccus denitrificans

artículo científico publicado en 1983

Type and location of isocitrate dehydrogenase mutations influence clinical characteristics and disease outcome of acute myeloid leukemia

artículo científico publicado en 2012

Unexpected biochemical and pharmacogenetic consequences of SNPs and haplotypes: a cautionary tale for human molecular genetics and epidemiology

artículo científico publicado en 2006

Vaginal agenesis (Mayer-Rokitansky-Kuster-Hauser syndrome) associated with the N314D mutation of galactose-1-phosphate uridyl transferase (GALT).

artículo científico publicado en 1996

Zinc enhances temozolomide cytotoxicity in glioblastoma multiforme model systems

artículo científico publicado en 2016

Lista de obras de Juergen Reichardt

A genetic factor for age-related cataract: identification and characterization of a novel galactokinase variant, "Osaka," in Asians

A prevalent missense substitution that modulates activity of prostatic steroid 5alpha-reductase.

A reliable PCR amplification method for microdissected tumor cells obtained from paraffin-embedded tissue

A renaissance of "biochemical genetics"? SNPs, haplotypes, function, and complex diseases.

Androgen metabolic genes in prostate cancer predisposition and progression.

Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility

Androgen receptor CAG repeat length and TMPRSS2:ETS prostate cancer risk: results From the Prostate Cancer Prevention Trial.

Androgens and the molecular epidemiology of prostate cancer.

Association between two polymorphisms in the SRD5A2 gene and serum androgen concentrations in British men.

Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial

Association of galactose-1-phosphate uridyltransferase activity and N314D genotype with the risk of ovarian cancer

Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA

Association of the G289S single nucleotide polymorphism in the HSD17B3 gene with prostate cancer in Italian men.

Associations between polymorphisms in the steroid 5-alpha reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer

Associations of serum sex steroid hormone and 5α-androstane-3α,17β-diol glucuronide concentrations with prostate cancer risk among men treated with finasteride

Biochemical and molecular studies of 132 patients with galactosemia.

Biochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type II

Characteristics of women with a family history of ovarian cancer. I. Galactose consumption and metabolism

Characterization of a novel biochemical abnormality in galactosemia: deficiency of glycolipids containing galactose or N-acetylgalactosamine and accumulation of precursors in brain and lymphocytes

Characterization of two missense mutations in human galactose-1-phosphate uridyltransferase: different molecular mechanisms for galactosemia.

Characterization of two stop codon mutations in the galactose-1-phosphate uridyltransferase gene of three male galactosemic patients with severe clinical manifestation

Conservation of short patches of amino acid sequence amongst proteins with a common function but evolutionarily distinct origins: implications for cloning genes and for structure-function analysis

Correlation of cognitive, neurologic, and ovarian outcome with the Q188R mutation of the galactose-1-phosphate uridyltransferase gene.

Current progress in using vitamin D and its analogs for cancer prevention and treatment ⬇️

Differential expression of steroid 5alpha-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancer.

Effect of finasteride on serum androstenedione and risk of prostate cancer within the prostate cancer prevention trial: differential effect on high- and low-grade disease

Evidence for an association between the SRD5A2 (type II steroid 5 alpha-reductase) locus and prostate cancer in Italian patients.

Expression of galactose-1-phosphate uridyltransferase in the anterior pituitary of rat during the estrous cycle

Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention Trial

Finasteride metabolism and pharmacogenetics: new approaches to personalized prevention of prostate cancer.

First International Conference on Chemoprevention of Prostate Cancer. Overview consensus statement

Galactose-1-phosphate uridyl transferase (GALT) genotype and phenotype, galactose consumption, and the risk of borderline and invasive ovarian cancer (United States).

Genetic basis of galactosemia

Genetic variability of the human SRD5A2 gene: implications for prostate cancer risk.

Genetic variation of 3 beta-hydroxysteroid dehydrogenase type II in three racial/ethnic groups: implications for prostate cancer risk

Genomic analysis of cancer tissue reveals that somatic mutations commonly occur in a specific motif.

Genomic biomarkers, androgen pathway and prostate cancer.

Genomics in breast and prostate cancer: assessment of the current state and future perspectives.

Genomics is changing personal healthcare and medicine: the dawn of iPH (individualized preventive healthcare).

Hormones and prostate cancer: current perspectives and future directions

Human UDP-galactose 4' epimerase (GALE) gene and identification of five missense mutations in patients with epimerase-deficiency galactosemia

Human genetics and genomics meetings going virtual: practical lessons learned from two international meetings in early 2020

Identification and characterization of somatic steroid 5alpha-reductase (SRD5A2) mutations in human prostate cancer tissue

Identification of genomic aberrations in hemangioblastoma by droplet digital PCR and SNP microarray highlights novel candidate genes and pathways for pathogenesis

In vitro read-through of phenylalanine hydroxylase (PAH) nonsense mutations using aminoglycosides: a potential therapy for phenylketonuria

In vivo and in vitro expression of rat galactose-1-phosphate uridyltransferase (GALT) in the developing central and peripheral nervous system

Increasing PCR sensitivity for amplification from paraffin-embedded tissues

Information symmetries in irreversible processes.

Linkage disequilibrium between a SacI restriction fragment length polymorphism and two galactosemia mutations

Modeling single nucleotide polymorphisms in the human AKR1C1 and AKR1C2 genes: implications for functional and genotyping analyses

Molecular analysis of 11 galactosemia patients.

Molecular basis of disorders of human galactose metabolism: past, present, and future.

Molecular basis of galactosemia: mutations and polymorphisms in the gene encoding human galactose-1-phosphate uridylyltransferase

Molecular characterization of galactosemia (type 1) mutations in Japanese.

Molecular characterization of the H319Q galactosemia mutation.

Molecular characterization of two galactosemia mutations and one polymorphism: implications for structure-function analysis of human galactose-1-phosphate uridyltransferase.

Molecular cloning, characterization, and mapping of a full-length cDNA encoding human UDP-galactose 4'-epimerase

Molecular epidemiology of hormone-metabolic loci in prostate cancer

Molecular epidemiology of prostate cancer: hormone-related genetic loci

Multiplex automated primer extension analysis: simultaneous genotyping of several polymorphisms.

Mutations in galactosemia

No association between the SRD5A2 gene A49T missense variant and prostate cancer risk: lessons learned

Novel age-dependent targets in vestibular schwannomas.

On the molecular nature of the Duarte variant of galactose-1-phosphate uridyl transferase (GALT).

PCR-free method detects high frequency of genomic instability in prostate cancer.

Pharmacogenetic analysis of human steroid 5 alpha reductase type II: comparison of finasteride and dutasteride

Pharmacogenetics of human androgens and prostate cancer--an update.

Pharmacogenomics of brain cancer and personalized medicine in malignant gliomas

Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.

Quo vadis, genoma? A call to pipettes for biochemists

Realizing the full potential of the sequenced human genome

Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial

Robustness of gene expression profiling in glioma specimen samplings and derived cell lines.

Schwannomas exhibit distinct size-dependent gene-expression patterns.

Screening of nine SLC25A13 mutations: their frequency in patients with citrin deficiency and high carrier rates in Asian populations

Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial

Sex steroid hormones and genetic susceptibility to breast and prostate cancer

Single nucleotide differences (SNDs) continue to contaminate the dbSNP database with consequences for human genomics and health

Single nucleotide differences (SNDs) in the dbSNP database may lead to errors in genotyping and haplotyping studies